Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Allison P Watson"'
Autor:
Megan M. Ahearne, Ligia L. Pentzke‐Lemus, Ashley M. Romano, Eileen D. Larsen, Allison M. Watson, Elsbeth A. O'Fallon, Gabriele A. Landolt
Publikováno v:
Journal of Veterinary Internal Medicine, Vol 36, Iss 6, Pp 2230-2237 (2022)
Abstract Background Equine influenza virus is a common cause of respiratory disease in equids. Few reports describe clinical presentation and disease progression in donkeys. Hypothesis/Objectives Describe the clinical and diagnostic findings, outcome
Externí odkaz:
https://doaj.org/article/31fc2e90e0d744aeb3fc528a4460e709
Publikováno v:
Animals, Vol 12, Iss 23, p 3421 (2022)
Colic remains the number one cause of mortality in horses, and large colon displacement including colonic volvulus is one of the leading causes for equine hospitalization and surgery. Currently, there is not an adequate model to study the pathophysio
Externí odkaz:
https://doaj.org/article/dd6830a09a974987a3d2c2d2115825ee
PDF file - 4.4MB, Immunohistochemical analysis on cell lines using anti-SUSD2 antibody
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::369cf3e52b0e3b69bb3eeae4a8a03b4c
https://doi.org/10.1158/1541-7786.22517548
https://doi.org/10.1158/1541-7786.22517548
Publikováno v:
Case Reports in Transplantation, Vol 2018 (2018)
Ruxolitinib is an oral selective Janus-associated kinase 1 (JAK1) and JAK2 inhibitor that was initially approved by the FDA in 2014 for treatment of myelofibrosis. In preclinical and retrospective clinical studies, use of ruxolitinib was shown to red
Externí odkaz:
https://doaj.org/article/4fd6d588feee4a43a6267dccd6fcb434
Autor:
Celalettin Ustun, Smarika Sapkota, Jo Anne H. Young, Qing Cao, Daniel J. Weisdorf, Steven Richmond, Karam M. Obeid, Timothy L. Pruett, Allison P Watson, Fatma Keklik Karadag
Publikováno v:
Transplant infectious disease : an official journal of the Transplantation SocietyREFERENCES. 24(1)
Background Clostridioides difficile infection (CDI) frequently complicates allogeneic hematopoietic stem cell (allo-HCT) and solid organ transplantation (SOT). Methods We retrospectively analyzed risk factors and outcomes of CDI occurring within 30 d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df5c254ba509b978b5d790d9176f3ce8
https://pubmed.ncbi.nlm.nih.gov/34455662
https://pubmed.ncbi.nlm.nih.gov/34455662
Autor:
Allison P, Watson, Ashraf, Shabaneh, Jinhua, Wang, Scott M, Dehm, Arpit, Rao, Charles J, Ryan
Publikováno v:
Am J Clin Exp Urol
Background: Aberrations in TP53, PTEN and RB1 are key drivers of therapy resistance in prostate cancer. Up to 50% of prostate cancers harbor ETS gene rearrangements, a potentially compounding aggressive biological event. Little is known about the imp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::63b77891488aa695a9beb73c01559480
https://pubmed.ncbi.nlm.nih.gov/32929406
https://pubmed.ncbi.nlm.nih.gov/32929406
Autor:
Sharon Luikart, Allison P Watson, Daniel S. O'Leary, Audrey A Jacobsen, Kevin J. Gaddis, Amrita Goyal
Publikováno v:
Dermatology Online Journal. 26
A 61-year-old man with metastatic renal cell carcinoma on cabozantinib developed hand-foot skin reaction with predominantly dorsal involvement including painful violaceous plaques over the joints and keratotic yellow plaques on the palmar fingers. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f6b1edebf3ecaf6a2dc3b34135397e85
https://doi.org/10.5070/d3268049894
https://doi.org/10.5070/d3268049894
Autor:
Allison P Watson, Anne H. Blaes, Rachel Isaksson Vogel, Bruce A. Peterson, Chung Lee, Lucie M. Turcotte, Kate Baxstrom
Publikováno v:
Cancer Treatment and Research Communications. 15:1-6
MicroAbstract Women treated with chest radiation for Hodgkin lymphoma (HL) have significantly higher risk of developing breast cancer, and little is known about how these patients tolerate chemotherapy for breast cancer. This small retrospective stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f3dbf7f4585a8c34cdd75992291a1f3
https://doi.org/10.1016/j.ctarc.2018.02.001
https://doi.org/10.1016/j.ctarc.2018.02.001
Autor:
Haiyun Wang, Douglas Yee, Anne H. Blaes, Christina Yau, Nicholas O'Grady, Amy Wilson, Susie Brain, Allison P Watson, David Potter, Heather Beckwith, Patricia Jewett
Publikováno v:
Cancer Research. 81:PS6-05
Purpose: Increased body mass index (BMI) is a risk factor for breast cancer and has been associated with poor outcomes in both premenopausal and postmenopausal breast cancer patients. Several retrospective studies have demonstrated higher BMI to be a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::abf3d3085f61ca9efbaa2d044ae99c97
https://doi.org/10.1158/1538-7445.sabcs20-ps6-05
https://doi.org/10.1158/1538-7445.sabcs20-ps6-05